Takatsuki-shi, Osaka, Japan Clinical Trials

A listing of Takatsuki-shi, Osaka, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 120 clinical trials
Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

This study is non-randomized, multicenter, confirmatory study by intrathecal administration of KP-100IT, code of HGF (Hepatocyte Growth Factor ) formulation for intrathecal injection, in subjects with acute spinal cord injury.

Aijinkai Rehabilitation Hospital
 (0.6 away) Contact site
  • 0 views
  • 19 Mar, 2021
  • +4 other locations
Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection

This trial is a randomized, double-blind, multinational Phase III study to evaluate the efficacy and safety of preemptive treatment with FTD/TPI compared with administration of placebo as follow-up, which is the standard of care, in patients who underwent curative resection of colorectal cancer and then tested positive for ctDNA.

adenocarcinoma
tas-102
colon cancer
neutrophil count
metastasis
Osaka Medical College Hospital
 (0.6 away) Contact site
  • 0 views
  • 07 Mar, 2021
  • +36 other locations
Crisaborole for Chinese and Japanese Subjects ( 2 Years of Age) With Mild to Moderate Atopic Dermatitis

This study is a phase 3, randomized, double blind and vehicle study to evaluate the efficacy and safety of Crisaborole ointment, 2% in Chinese and Japanese subjects with mild to moderate atopic dermatitis involving at least 5% treatable BSA. Eligible subjects will be randomized in a 2:1 ratio to one …

crisaborole ointment
crisaborole
atopy
Yoshioka Dermatology Clinic
 (5.5 away) Contact site
  • 7 views
  • 25 Jul, 2021
  • +48 other locations
Dupilumab in Japanese Patients With Atopic Dermatitis

Primary Objective: To evaluate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) Secondary Objective: To evaluate the efficacy of dupilumab administered concomitantly with TCS. To assess the safety of dupilumab over 16 weeks of treatment when administered concomitantly with TCS in participants. To assess immunogenicity as determined by …

Investigational Site Number 3920019
 (9.4 away) Contact site
  • 0 views
  • 27 Jan, 2021
  • +4 other locations
Phase III Trial of Stage I Ovarian Cancer After Surgery

To compare the Overall survival of adjuvant chemotherapy versus observation in stage I epithelial ovarian cancer after comprehensive staging surgery

Osaka Medical College Hospital
 (0.6 away) Contact site
  • 0 views
  • 23 Jan, 2021
  • +102 other locations
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in combination with a topical corticosteroids in Japanese participants with atopic dermatitis.

Yoshikawa Dermatology Clinic
 (1.8 away) Contact site
  • 0 views
  • 15 May, 2021
  • +36 other locations
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)

The purpose of this study is to evaluate the efficacy of ustekinumab compared to placebo, in combination with oral glucocorticoid (GC) taper regimen, in participants with relapsing Takayasu Arteritis (TAK).

National Cerebral and Cardiovascular Center Hospital
 (8.3 away) Contact site
  • 0 views
  • 26 Jul, 2021
  • +23 other locations
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

This study will evaluate the efficacy and safety of trastuzumab deruxtecan (T-DXd) compared with ramucirumab and paclitaxel (Ram + PTX) in participants with HER2-positive gastric or gastro-esophageal junction (GEJ) adenocarcinoma who have progressed on or after a trastuzumab-containing regimen and have not received any additional systemic therapy.

Osaka University Hospital
 (5.6 away) Contact site
  • 0 views
  • 19 Jul, 2021
  • +8 other locations
A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

The main aim of this study is to check the safety of TAK-536. This study will take place in Japan. At the first visit, the study doctor will check if each child can take part. For those who can take part, each participant will have a check-up by the study …

hypertension
essential hypertension
antihypertensive drugs
systolic blood pressure
diabetes
Osaka University Hospital
 (5.6 away) Contact site
  • 0 views
  • 17 Jul, 2021
  • +17 other locations
A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease

The main purpose of this study is to learn more about tirzepatide in participants with obesity disease. The study will also measure how Tirzepatide affects body weight with a low-calorie diet and increased physical activity. The study will last around 72 Weeks.

calorie diet
Takatsuki Red Cross Hospital
 (2.4 away) Contact site
  • 0 views
  • 19 Jun, 2021
  • +17 other locations